Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Jennifer S. Temel"'
Autor:
Jennifer S, Temel, David M, Dudzinski, Subba R, Digumarthy, Colleen M, Keyes, Florence K, Keane, Daniel, Shepherd
Publikováno v:
New England Journal of Medicine. 387:1889-1896
Autor:
Sarah K. Andersen, Grace Vincent, Rachel A. Butler, Elke H.P. Brown, Dave Maloney, Sana Khalid, Rae Oanesa, James Yun, Carrie Pidro, Valerie N. Davis, Judith Resick, Aaron Richardson, Kimberly Rak, Jackie Barnes, Karl B. Bezak, Andrew Thurston, Eva Reitschuler-Cross, Linda A. King, Ian Barbash, Ali Al-Khafaji, Emily Brant, Jonathan Bishop, Jennifer McComb, Chung-Chou H. Chang, Jennifer Seaman, Jennifer S. Temel, Derek C. Angus, Robert Arnold, Yael Schenker, Douglas B. White
Publikováno v:
J Pain Symptom Manage
BACKGROUND: Each year, approximately one million older adults die in American ICUs or survive with significant functional impairment. Inadequate symptom management, surrogates’ psychological distress and inappropriate healthcare use are major conce
Autor:
Satoshi Yoda, Wafa Malik, Adam Langenbucher, Justin F. Gainor, Sai-Hong Ignatius Ou, Kylie Prutisto-Chang, Ramin Sakhtemani, Jennifer L Peterson, Aaron N. Hata, Alexander Drilon, Andrew Do, Jessica J. Lin, Adam J. Schoenfeld, Viola W. Zhu, Ted William Johnson, Jochen K. Lennerz, Lecia V. Sequist, Noura J. Choudhury, Ibiayi Dagogo-Jack, Subba R. Digumarthy, Christina Falcon, Charlotte E. Lee, Alice T. Shaw, Michael S. Lawrence, Beow Y. Yeap, Jennifer S. Temel, Harper Hubbeling
Publikováno v:
Clin Cancer Res
Purpose: Current standard initial therapy for advanced, ROS proto-oncogene 1, receptor tyrosine kinase fusion (ROS1)-positive (ROS1+) non–small cell lung cancer (NSCLC) is crizotinib or entrectinib. Lorlatinib, a next-generation anaplastic lymphoma
Autor:
Florian J. Fintelmann, Christopher P. Bridge, Jennifer S. Temel, Areej El-Jawahri, J. Peter Marquardt, Eric Roeland, Till D. Best, Michael H. Rosenthal, Chinenye C. Azoba, Nora Horick, Emily E. Van Seventer, Amelie S. Troschel, Joseph A. Greer, Ryan D. Nipp, Richard Newcomb
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:319-327
Background: Low muscle mass (quantity) is common in patients with advanced cancer, but little is known about muscle radiodensity (quality). We sought to describe the associations of muscle mass and radiodensity with symptom burden, healthcare use, an
Autor:
Lara Traeger, Joseph A. Greer, Ashley M. Nelson, Annemarie D. Jagielo, Jennifer S. Temel, Jamie M. Jacobs, Jennifer D'Alotto, Lauren Waldman, Showly Nicholson, Areej El-Jawahri
Publikováno v:
Cancer
BACKGROUND: In a recent trial, a six-session intervention (BMT-CARE) that integrated medical information with cognitive-behavioral strategies improved quality of life (QOL), mood, coping skills, and self-efficacy in family/friend caregivers of hemato
Autor:
Olivia Vanbenschoten, Zhigang Li, Sunil Bhatt, Joseph A. Greer, Areej El-Jawahri, Nora Horick, Netana Markovitz, Kerry L. Reynolds, Barbara J. Cashavelly, Sarah Fishman, Jennifer S. Temel, Lipika Goyal, Angelo E. Volandes, Ryan D. Nipp, Lara Traeger, Lee Ann Tata
Publikováno v:
Cancer. 126:3569-3578
BACKGROUND Patients with advanced cancer and their caregivers have substantial misperceptions regarding hospice, which contributes to its underuse. METHODS The authors conducted a single-site randomized trial of a video educational tool versus a verb
Autor:
Nwamaka D. Eneanya, Tamar Klaiman, Shananssa G. Percy, Jennifer S. Temel, Elyse R. Park, Allison K. Labbe, Taylor L. Stallings
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2020)
BMC Nephrology
BMC Nephrology
Background Older patients with advanced chronic kidney disease often do not understand treatment options for renal replacement therapy, conservative kidney management, and advance care planning. It is unclear whether both clinicians and patients have
Autor:
Areej El-Jawahri, Alyssa L. Fenech, Annemarie D. Jagielo, Jennifer D'Alotto, Jamie M. Jacobs, Showly Nicholson, Lara Traeger, Yi Bin Chen, Joseph A. Greer, Lauren Waldman, Zachariah DeFilipp, Ashley M. Nelson, Thomas R. Spitzer, Jennifer S. Temel, Nora Horick
Publikováno v:
Cancer
BACKGROUND Caregivers of patients undergoing hematopoietic stem cell transplantation (HCT) experience an immense caregiving burden before, during, and after HCT. METHODS We conducted an unblinded, randomized trial of a psychosocial intervention (BMT-
Autor:
Chrisa Hunnewell, Joseph A. Greer, Areej El-Jawahri, Robert K. Sommer, Sarah Fishman, Jennifer S. Temel, Zachariah DeFilipp, Thomas R. Spitzer, Jamie M. Jacobs, Amanda L. Jankowski, Isabella Sereno, Yi Bin Chen, Lara Traeger, Alyssa L. Fenech, Julie Vanderklish, Meredith Saylor
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2234-2242
Chronic graft-versus-host disease (GVHD) is one of most common complications following allogeneic hematopoietic cell transplantation (HCT) and the most significant contributor to morbidity and nonrelapse mortality. The physical burdens and psychosoci
Autor:
Patrick Connor Johnson, Eric Roeland, Areej El-Jawahri, Jennifer S. Temel, Emily E. Van Seventer, Christopher P. Bridge, Madeleine Fish, Florian J. Fintelmann, Nora Horick, Katie Kanter, Ryan D. Nipp, Amelie S. Troschel, Ryan B. Corcoran, J. Peter Marquardt, Till D. Best
Publikováno v:
The Oncologist
Background Survival in patients with metastatic colorectal cancer (mCRC) has been associated with tumor mutational status, muscle loss, and weight loss. We sought to explore the combined effects of these variables on overall survival. Materials and M